Bortezomib - Latest Advances

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID -Dexamethasone versus Rituximab in PGNMID.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 23, 2026

Dexamethasone activates anti-tumor immunity in multiple myeloma by dismantling the GR-PPP1CB complex to restore STING/IRF3 signaling.

Journal: Journal for immunotherapy of cancer

Published: June 08, 2026

Transcript architecture predetermines m6A remodeling and sensory neuron vulnerability in chemotherapy-induced peripheral neuropathy.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2026

Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 03, 2026

Recent advances in management of systemic AL amyloidosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 03, 2026

A Single Center Real-World Study of the Efficacy of Daratumumab-Based Regimens in the Treatment of Relapsed/Refractory Multiple Myeloma Patients

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 02, 2026

Response to comment on "Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: June 01, 2026

Crescentic Glomerulonephritis in a Patient With AL Amyloidosis: A Case Report.

Journal: Kidney medicine

Published: June 01, 2026

Bortezomib/SBE-β-cyclodextrin inclusion complex for improved anticancer performance: formulation, characterization, and biological evaluation.

Journal: Pharmaceutical development and technology

Published: May 31, 2026

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 29, 2026

Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.

Journal: The New England journal of medicine

Published: May 29, 2026

T-cell acute lymphoblastic leukemia in adults: current treatment approaches and future perspectives.

Journal: Expert review of hematology

Published: May 21, 2026